Draft:Ubie
Submission declined on 8 October 2024 by Drmies (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 8 October 2024 by Drmies (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by Drmies 8 minutes ago.
| |
Comment: Removing press releases is only one of the necessary steps. Can you please actually work on this before resubmitting? This is taking up volunteer time. Drmies (talk) 19:55, 8 October 2024 (UTC)
 | |
| Company type | Corporation |
|---|---|
| Industry | Healthcare service |
| Founded | 2017 |
| Founders |
|
| Headquarters | Tokyo, Japan |
Area served | United States, Japan |
| Products |
|
 ¥3.843 billion (2023) | |
| Total assets |  ¥1.908 billion (2023) |
Number of employees | 280 (2023) |
| Website | ubiehealth |
Ubie Inc. is a health technology company founded in May 2017 by physician Yoshinori Abe and machine learning engineer Kota Kubo. Headquartered in Tokyo and operating in both the U.S. and Japan, Ubie develops AI solutions for healthcare, including tools like symptom checkers for consumers and clinical support software for providers. The company’s mission is to make healthcare more accessible, empowering people to access medical information and care using AI technology. The name "Ubie" derives from the Japanese word "指 (yubi)," meaning "fingers," symbolizing easy access to healthcare.[1]
History
[edit]Ubie's foundation was laid in 2013 when Kota Kubo began using AI to study correlations between symptoms and diseases during his graduate studies at the University of Tokyo. In 2014, Yoshinori Abe joined to curate a comprehensive dataset from around 50,000 research papers. In 2017, they co-founded Ubie to improve healthcare accessibility using AI technology. That same year, Ubie launched Dr. Ubie, an Android app that provides symptom-based medical information. In 2018, Ubie introduced the AI Health Assistant for healthcare providers, streamlining patient intake processes and reducing documentation burdens. Ubie also raised ¥60 million in funding and won the "Disease Awareness Award" at Pfizer's Healthcare Hub Japan.
Initial Expansion and Collaborations
[edit]By 2019, Ubie's solutions were implemented in six major Japanese hospitals. With the company’s growth, Ubie secured ¥510 million in funding from Kansai Electric Power Co., Ltd. and other investors. In 2020, Ubie launched its browser-based AI Symptom Checker, which helps users identify potential diseases and access educational resources, reaching 7 million monthly users within three years.
During the COVID-19 pandemic, Ubie launched a COVID-19 triage system and partnered with NTT East and NTT West to provide secure VPN solutions for hospitals. The same year, Ubie expanded internationally with a Singapore subsidiary and collaborated with AstraZeneca to enhance AI solutions for conditions like Chronic Obstructive Pulmonary Disease.[2]
Strategic Partnerships and International Expansion
[edit]In 2021, Ubie partnered with pharmaceutical companies, including Takeda, Pfizer, and Bayer, to improve disease detection and patient engagement. The company expanded further in 2022, raising ¥6.26 billion and establishing a U.S. subsidiary. The U.S. version of Ubie's AI Symptom Checker quickly gained over 100,000 monthly users within its first three months and surpassed 2 million users in its first year.[3]
Recent Developments
[edit]In 2023, Ubie held its first "Ubie Pharma Summit," focusing on patient-centric AI in healthcare. Ubie also launched Ubie Lab, a research organization aimed at advancing AI safety and innovation, and developed the Patient-Centricity Assessment tool for pharmaceutical companies. The AI Symptom Checker surpassed 100 million cumulative uses within three years, earning Ubie the "Best AI Award" in Google Play’s Best of 2023 rankings.
U.S. Expansion and Activities
[edit]Ubie entered the U.S. market in October 2022, launching a browser-based AI Symptom Checker and forming partnerships with healthcare organizations like ZocDoc, HealthTap, and Sesame Health. In July 2024, Ubie partnered with the American Kidney Fund (AKF) to enhance kidney disease prediction through AI and support educational resources for patients.
- in-depth (not just brief mentions about the subject or routine announcements)
- reliable
- secondary
- strictly independent of the subject
Make sure you add references that meet all four of these criteria before resubmitting. Learn about mistakes to avoid when addressing this issue. If no additional references exist, the subject is not suitable for Wikipedia.